PYRIMIDINE NUCLEOSIDE PHOSPHORYLASES IN CHEMOTHERAPY
PYRIMIDINE NUCLEOSIDE PHOSPHORYLASES IN CHEMOTHERAPY
批准号:
3178382
负责人:
SHIH-HSI CHU
金额:
$14.05万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
1985
资助国家:
美国
项目状态:
已结题
起止时间:
1985-09-01 至 1992-11-30
关键词:
antimetabolites drug design /synthesis /production drug metabolism drug screening /evaluation enzyme inhibitors floxuridine neoplasm /cancer chemotherapy neoplasm /cancer pharmacology nucleic acid metabolism pentosyltransferase pyrimidine nucleosides thymidylate synthase uracil uridine phosphorylase
中文摘要
点击翻译按钮获取中文摘要
英文摘要
The objectives of this grant proposal are:
1. Chemical synthesis of analogs and derivatives of BAU
(5-benzylacyclouridine) and BBAU (5-benzyloxybenzylacyclouridine), potent
inhibitors of uridine phosphorylase and potentiators of the anti-tumor
action of FUdR, designed to improve facility of clinical use, to produce
new anti-tumor drugs and pro-drugs, and to explore further their biological
properties.
2. Biological testing of these new agents as inhibitors of uridine
phosphorylase and, where indicated, thymidine phosphorylase, as transport
inhibitors, anti-tumor agents and potentiators both in vitro and in vivo,
and as tools for obtaining new biochemical knowledge related to nucleic
acid metabolism.
These studies will be performed in collaboration with colleagues in the
Roger Williams Cancer Center.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
CORE--MEDICINAL CHEMISTRY
-
批准号:3751846
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:SHIH-HSI CHU
-
依托单位:
CORE--MEDICINAL CHEMISTRY
-
批准号:3774176
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:SHIH-HSI CHU
-
依托单位: